BackAdverum Biotechnologies Overview

Adverum Biotechnologies Cost of Revenue

Cost of Revenue analysis for ADVM.

Quarterly Cost of Revenue

$465000.00
47.75% YoY

As of Sep 30, 2025

Annual Cost of Revenue (TTM)

$1.81M
53.01% YoY

Trailing 12 months ending Sep 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)